Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BrainBase

Financiado

Cerrado

Knowledge management platform for clinical use of brain data

The connectome is a map of all neural connections in the brain that can provide information about the brain’s (re)wiring in neurological diseases, injuries, or drugs responses. The use of connectomes in clinical practice has enorm... ver más

28/02/2019

BIOMAX

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

BIOMAX INFORMATICS AG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 4 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-02-28

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

4 Participantes

BIOMAX

50.00K€ | Lider

ALMUPLAS SL

297.42K€ | Participante

TALLERES PENA

251.36K€ | Participante

TALLERES RUBLA

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

outGRID A WORLDWIDE E INFRASTRUCTURE FOR COMPUTATIONAL NEUROSCIENTIS... 492K€ Cerrado

Neuro-Metrology Brain connectivity metrology for personalised neuroimaging i... 2M€ Cerrado

Neuromapper Cloud collaborative open platform for advanced brain analyti... 71K€ Cerrado

zelig Matched Sampling Approaches for Statistical Inference in Lar... 171K€ Cerrado

PRECONFIG Learning and PREdiction based on the PREnatal CONnectome FIn... 178K€ Cerrado

TRABIT Translational Brain Imaging Training Network 4M€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2018-08-02
Fecha Fin: 2019-02-28

Líder del proyecto

BIOMAX INFORMATICS AG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The connectome is a map of all neural connections in the brain that can provide information about the brain’s (re)wiring in neurological diseases, injuries, or drugs responses. The use of connectomes in clinical practice has enormous potential to improve treatment efficacy, enhance patient stratification, disease characterization, and ultimately diagnosis. However, the means to clinically utilize connectomes are limited. Therefore neurologists still rely on subjective analysis of brain scans. Although the use of big data tools in neuro-diagnostics is growing, no commercial application for clinical practice is available yet. Biomax developed the first commercial solution to translate big connectome data into clinically relevant information: NeuroXM. In combination with patients’ clinical data this can be valorized to improve neuro-diagnosis. NeuroXM has successfully undergone pilot studies at two major institutes. The proprietary NeuroXM platform includes all features and security levels that are required in the clinic. Biomax is a strong bioinformatic SME with 20 years’ experience, including >25 European grants, 5 successful bioinformatic products, and a pioneering reputation. NeuroXM targets a very large and diverse neurology market with multiple clinical applications, e.g. diagnosis of dementia using brain imaging, detecting brain wiring disconnections in schizophrenia, and establishing treatment efficacy (longitudinal assessments of the connectome). This SME Phase 1 project will assess the feasibility of these different applications, which will help Biomax to establish a Go/No-go for further clinical validation for the specific clinical applications. With a strong first mover advantage and freedom to operate, NeuroXM has the potential to become the gold standard for working with connectome data. Commercialization of NeuroXM will provide Biomax a cumulative revenue of €47,4 million (2025) and further company growth.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores